Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03PDY
|
||||
Former ID |
DNC001298
|
||||
Drug Name |
SB-332235
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Chronic obstructive pulmonary disease [ICD9: 490-492, 494-496; ICD10:J40-J44, J47] | Discontinued in Phase 1 | [1] | ||
Company |
GlaxoSmithKline
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C13H10Cl3N3O4S
|
||||
Canonical SMILES |
C1=CC(=C(C(=C1)Cl)Cl)NC(=O)NC2=C(C(=C(C=C2)Cl)S(=O)(=O)<br />N)O
|
||||
InChI |
1S/C13H10Cl3N3O4S/c14-6-2-1-3-8(10(6)16)18-13(21)19-9-5-4-7(15)12(11(9)20)24(17,22)23/h1-5,20H,(H2,17,22,23)(H2,18,19,21)
|
||||
InChIKey |
WTLRWOHEKQGKDS-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 276702-15-9
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | High affinity interleukin-8 receptor B | Target Info | Antagonist | [2] | |
KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
Chemokine signaling pathway | |||||
Endocytosis | |||||
Epithelial cell signaling in Helicobacter pylori infection | |||||
NetPath Pathway | TNFalpha Signaling Pathway | ||||
PANTHER Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | ||||
Interleukin signaling pathway | |||||
Pathway Interaction Database | IL8- and CXCR2-mediated signaling events | ||||
Reactome | Chemokine receptors bind chemokines | ||||
G alpha (i) signalling events | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Peptide GPCRs | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014165) | ||||
REF 2 | Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs. 2006 May;11(2):275-91. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.